Singapore, May 21 -- MediThinQ, the South Korean startup specialising in wearable extended reality (XR) surgical displays, has announced a strategic partnership with Sinopharm, a state-owned Chinese healthcare giant and the largest pharmaceutical and medical distribution company in China.

This partnership - which includes an exclusive distribution agreement for MediThinQ's flagship product, Scopeye, in China - marks MediThinQ's entry into one of the world's largest healthcare markets.

Through Sinopharm's extensive network, Scopeye will be available in major hospitals across China, revolutionising how surgeons access critical information during live surgeries.

Published by HT Digital Content Services with permission from BioSpectrum Asi...